Seer Inc (SEER) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Seer Inc (SEER) has a cash flow conversion efficiency ratio of -0.042x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-9.57 Million) by net assets ($225.68 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Seer Inc for the company's overall valuation and market capitalisation.
Seer Inc - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Seer Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Seer Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Seer Inc ranked by their cash flow conversion efficiency. See SEER debt coverage from operations to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PT Buana Artha Anugerah Tbk
JK:STAR
|
-0.003x |
|
Protech Mitra Perkasa Tbk PT
JK:OASA
|
-0.061x |
|
Bogota Financial Corp
NASDAQ:BSBK
|
0.002x |
|
UBcare. Co. Ltd
KQ:032620
|
0.001x |
|
icad inc
NASDAQ:ICAD
|
0.002x |
|
Yi Jinn Industrial Co Ltd
TW:1457
|
0.020x |
|
Yoosung T&S Co. Ltd
KQ:024800
|
0.004x |
|
Zeotech Ltd
AU:ZEO
|
-0.080x |
Annual Cash Flow Conversion Efficiency for Seer Inc (2018–2025)
The table below shows the annual cash flow conversion efficiency of Seer Inc from 2018 to 2025. View SEER share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $259.31 Million | $-44.45 Million | -0.171x | -21.77% |
| 2024-12-31 | $327.57 Million | $-46.11 Million | -0.141x | +5.41% |
| 2023-12-31 | $396.90 Million | $-59.06 Million | -0.149x | -9.44% |
| 2022-12-31 | $446.99 Million | $-60.78 Million | -0.136x | -47.55% |
| 2021-12-31 | $502.92 Million | $-46.35 Million | -0.092x | -90.97% |
| 2020-12-31 | $431.61 Million | $-20.83 Million | -0.048x | +67.63% |
| 2019-12-31 | $87.68 Million | $-13.07 Million | -0.149x | +3.91% |
| 2018-12-31 | $29.98 Million | $-4.65 Million | -0.155x | -- |
About Seer Inc
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis … Read more